Efficacy and safety of hydroxychloroquine for treatment of patients with rosacea: A multicenter, randomized, double-blind, double-dummy, pilot study - 11/01/21

Ben Wang, MD ^{a, b}, Xin Yuan, MD ^a, Xin Huang, MD ^c, Yan Tang, MD ^{a, b}, Zhixiang Zhao, MD ^{a, b}, Bin Yang, MD ^d, Baoqi Yang, MD ^e, Yue Zheng, MD ^f, Chao Yuan, MD ^g, Hongfu Xie, MD, PhD ^{a, b, h, ⁎} , Ji Li, MD, PhD ^{a, b, h, i, ⁎}

^a Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China 

^b National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China 

^c Department of Preventive Medicine, the Medicine School of Hunan Normal University, Changsha, Hunan, China 

^d Guangdong Provincial Dermatology Hospital, Guangzhou, Guangdong, China 

^e Shandong Provincial Hospital of Dermatology, Jinan, Shandong, China 

^f Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China 

^g Shanghai Dermatology Hospital, Shanghai, China 

^h Key Laboratory of Organ Injury, Aging and Regenerative Medicine of Hunan Province, Central South University, Changsha, Hunan, China 

ⁱ Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China 

^∗Correspondence to: Ji Li, MD, PhD, Department of Dermatology, Xiangya Hospital, Central South University, Xiangya Rd, Kaifu District, Changsha 410008, ChinaDepartment of DermatologyXiangya HospitalCentral South UniversityXiangya Rd, Kaifu DistrictChangsha410008China^∗Correspondence to: Hongfu Xie, MD, PhD, Department of Dermatology, Xiangya Hospital, Central South University, Xiangya Rd, Kaifu District, Changsha 410008, ChinaDepartment of DermatologyXiangya HospitalCentral South UniversityXiangya Rd, Kaifu DistrictChangsha410008China